文献速递中医内科中药与中成药合理使用

植物代谢物调控M1/M2巨噬细胞极化:类风湿关节炎治疗策略

Modulating M1/M2 macrophage polarization with plant metabolites: a therapeutic strategy for rheumatoid arthritis.
PubMed 文献 · Front Pharmacol · 2025-10-17

该综述总结植物代谢物通过调控M1/M2巨噬细胞极化平衡治疗类风湿关节炎(RA)的潜在机制。RA为系统性自身免疫病,巨噬细胞极化失衡是关键致病因素。植物代谢物具多成分、多靶点、多通路特征,现有证据提示其在RA管理中可能提供一定治疗获益及相对可控的安全性。

要点

  • M1/M2巨噬细胞极化失衡是RA发病与进展的关键环节。
  • 植物代谢物可调控巨噬细胞功能与极化平衡。
  • 现有证据提示植物代谢物对RA可能有一定治疗获益。

核心结论

  • 植物代谢物调控M1/M2巨噬细胞极化可能是RA治疗策略。
  • 现有证据提示此类代谢物在RA管理中可能提供一定治疗获益。
  • 其安全性相对可控。

研究设计与样本

  • 本文为综述,总结多种植物代谢物在炎症条件下调控巨噬细胞功能与极化的潜在机制。

主要发现

  • RA为系统性自身免疫病,特征为持续性滑膜炎及炎症所致关节软骨与周围骨破坏。
  • 多种免疫细胞尤其巨噬细胞参与RA炎症的启动与维持。
  • M1型巨噬细胞杀菌作用强,促进慢性炎症与组织损伤。
  • M2型巨噬细胞抑制炎症并促进组织修复。
  • 植物代谢物具多成分、多靶点、多通路作用特征。

临床怎么用

  • 可为RA精准治疗提供新思路。
  • 为植物代谢物临床应用于RA治疗提供证据参考。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rheumatoid arthritis (RA) is a systemic autoimmune disorder marked by persistent synovitis and the degradation of joint cartilage and surrounding bone due to inflammation. A variety of immune cells, particularly macrophages, are involved in the initiation and maintenance of inflammation in RA, along with leukocyte adhesion and migration, matrix breakdown, and neovascularization. Environmental and internal stimuli drive macrophages to polarize into two major phenotypes: M1, which exerts strong bactericidal effects and contributes to chronic inflammation and tissue injury, and M2, which inhibits inflammation and facilitates tissue repair. The dysregulation of M1/M2 macrophage polarization is a key contributor to the pathogenesis and disease progression of RA. Plant metabolites are typically characterized by multi-component, multi-target, and multi-pathway actions, and their underlying mechanisms may include regulation of immune function, especially the balance of macrophage polarization. Current evidence indicates that such metabolites may provide certain therapeutic benefits and a relatively manageable safety profile in the management of RA and related disorders. In this review, we summarize the potential mechanisms by which various plant metabolites modulate macrophage function and polarization under inflammatory conditions, providing evidence for their clinical application in RA treatment and offering new insights into precision therapy for RA.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Yang Y, Wang X, Kong Y, et al. Modulating M1/M2 macrophage polarization with plant metabolites: a therapeutic strategy for rheumatoid arthritis. Front Pharmacol. 2025. PMID: 41181606. doi:10.3389/fphar.2025.1651763

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。